Shares of vaccine makers, including Moderna, Pfizer, and BioNTech, dipped Tuesday after the Senate Finance Committee advanced Robert F. Kennedy Jr.'s nomination for Health and Human Services secretary.
The 14-13 party-line vote moved the controversial pick to the Senate floor. Kennedy, known for his skepticism of vaccines, has drawn sharp criticism for his previous comments on vaccine safety.
At 10:41 am ET, Moderna's stock fell 5.11% to $34.68, BioNTech dropped 2.97% to $116.26, and Pfizer slipped 1.77% to $25.73.